Concord Drugs Ltd.
BSE: 538965 | Sector: Health care |
NSE: N.A. | ISIN Code: INE858L01010 |
BSE 00:00 | 04 Mar | 26.15 |
1.20 (4.81%) |
OPEN
25.95 |
HIGH
26.15 |
LOW
25.95 |
NSE 05:30 | 01 Jan | Concord Drugs Ltd |
OPEN | 25.95 |
PREVIOUS CLOSE | 24.95 |
VOLUME | 56697 |
52-Week high | 32.80 |
52-Week low | 11.68 |
P/E | 56.85 |
Mkt Cap.(Rs cr) | 23 |
Buy Price | 26.15 |
Buy Qty | 502.00 |
Sell Price | 26.15 |
Sell Qty | 2148.00 |
About Concord Drugs Ltd.
CONCORD DRUGS LIMITED is a public limited company established in 1995 is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals Dry powder ) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets.State of the art technology having dedicated manufacturing facilitie...> More
Concord Drugs Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
23 | |
EPS - TTM | (![]() |
[*S] | 0.46 |
P/E Ratio | (X) | [*S] | 56.85 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 27.14 |
P/B Ratio | (![]() |
[*S] | 0.96 |
Announcement
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
-
Unaudited Financial Results For The Quarter Ended 31.12.2020
-
Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results For The
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
-
Statement Of Investor Complaints For The Quarter Ended December 2020
Concord Drugs Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | 8.24 | 10.91 | -24.47 |
Other Income | 3.53 | 0.02 | 17550 |
Total Income | 11.77 | 10.93 | 7.69 |
Total Expenses | 7.59 | 10.09 | -24.78 |
Operating Profit | 4.18 | 0.83 | 403.61 |
Net Profit | 2.7 | 0.04 | 6650 |
Equity Capital | 8.74 | 8.74 | - |
Concord Drugs Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Cian Healthcare | 13.80 | -3.16 | 32.24 |
Vista Pharma. | 8.65 | 0.58 | 31.83 |
Godavari Drugs | 40.40 | -1.34 | 30.42 |
Concord Drugs | 26.15 | 4.81 | 22.86 |
Transchem | 18.40 | 1.94 | 22.52 |
Sandu Pharma. | 30.00 | -1.80 | 21.24 |
Phaarmasia | 29.00 | -3.33 | 19.81 |
Concord Drugs Ltd - SHAREHOLDING PATTERN
|
|
Concord Drugs Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 3.56% | NA | -0.38% | -0.11% |
1 Month | 4.81% | NA | 0.46% | 1.24% |
3 Month | 11.51% | NA | 12.79% | 13.74% |
6 Month | 48.16% | NA | 32.56% | 33.06% |
1 Year | NA | NA | 32.38% | 34.04% |
3 Year | -4.39% | NA | 49.34% | 44.20% |
Concord Drugs Ltd - STOCK STRENGTH
Today's Low/High | 25.95 | 26.15 | |
Week Low/High | 23.55 | 27.00 | |
Month Low/High | 23.05 | 27.00 | |
YEAR Low/High | 11.68 | 33.00 | |
All TIME Low/High | 11.68 | 91.00 |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices